Pilot study of essential drug quality in two major cities in India

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Bate, Roger ^a,b   Tren, Richard ^a   Mooney, Lorraine ^c   Hess, Kimberly ^a   Mitra, Barun ^d   Debroy, Bibek ^e   Attaran, Amir ^f  

^a Africa Fighting Malaria   (United States)

^b AMERICAN ENTERPRISE INSTITUTE   (United States)

^c Africa Fighting Malaria   (United Kingdom)

^d Asia Fighting Malaria   (India)

^e CENTRE FOR POLICY RESEARCH   (India)

^f UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CIPROFLOXACIN; ERYTHROMYCIN; ISONIAZID; RIFAMPICIN; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; DRUG;

ARTICLE; DRUG MANUFACTURE; DRUG QUALITY; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; INDIA; LABORATORY TEST; PHARMACY; PILOT STUDY; QUANTITATIVE STUDY; STANDARD; TABLET DISINTEGRATION; THIN LAYER CHROMATOGRAPHY; DEVELOPING COUNTRY; DRUG CONTAMINATION; DRUG CONTROL; DRUG INDUSTRY; HUMAN; POSTMARKETING SURVEILLANCE; QUALITY CONTROL;

ANTI-BACTERIAL AGENTS; ANTIMALARIALS; DEVELOPING COUNTRIES; DRUG AND NARCOTIC CONTROL; DRUG CONTAMINATION; DRUG INDUSTRY; HUMANS; INDIA; PHARMACEUTICAL PREPARATIONS; PHARMACIES; PILOT PROJECTS; PRODUCT SURVEILLANCE, POSTMARKETING; QUALITY CONTROL;

EID: 67650330249     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006003     Document Type: Article

References (10)

1. European Commission, Taxation and Customs Union (2007) Report on Community Customs Activities on Counterfeit and Piracy: Results at the European Border. Available: http://ec.europa.eu/taxation_customs/ resources/documents/customs/customs_controls/counterfeit_piracy/ statistics2007.pdf. Accessed 2009 April 8.
2. World Health Organization (2006) Counterfeit medicines. Available: http://www.who.int/mediacentre/factsheets/fs275/en/index.html. Accessed 2009 April 8.
3. Government of India: Ministry of Health and Family Welfare (2003) Report of the Expert Committee on a Comprehensive Examination of Drug Regulatory Issues, Including the Problem of Spurious Drugs. Available: http://cdsco.nic.in/html/Final%20Report%20mashelkar.pdf. Accessed 2009 April 8.
4. Bate R, Coticelli P, Tren R, Attaran A (2008) Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa - A Six Country Study. PLoS ONE 3(5): e2132. doi:10.1371/journal.pone.0002132.
5. World Health Organization (2002) Effective Drug Regulation: A Multicountry Study. Available: http://www.who.int/medicinedocs/pdf/ s2300e/s2300e.pdf. Accessed 2009 April 8.
6. World Health Organization, Global Malaria Programme (2008) World Malaria Report. Available: http://www.who.int/malaria/wmr2008/. Accessed 2009 April 8.
7. World Health Organization (2009) Global Tuberculosis Control: Epidemiology, Strategy, Financing. Available: http://www.who.int/tb/ publications/global_report/2009/en/index.html. Accessed 2009 April 8.
8. NAFDAC Nigeria: Blacklisted Companies. Available: http://www.nafdacnigeria.org/blacklisted.html. Accessed 2009 April, 8.
9. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, et al. (2006) Counterfeit and substandard antimalarial drugs in Cambodia. Transactions of the Royal Society of Tropical Medicine and Hygiene 100: 1019-1024.
10. Global Pharma Health Fund E.V. (2008) GPHF-Minilab-Manuals. Available: http://www.gphf.org/web/en/minilab/manuals.htm. Accessed 2009 April 8.